The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

Nurse practitioners and physician assistants can advocate to play a number of roles in oncology research, including primary ...

According to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical ...

Both those receiving either expected or less-than-expected starting dosages of ruxolitinib for myelofibrosis treatment ...

AYA Cancer Awareness month offers an opportunity for nurses to go further in supporting AYAs with cancer.

The PFS benefit with T-DXd was observed across all prespecified patient subgroups. Overall survival (OS) data were not mature ...

For combination therapy, the FDA recommends 200 mg of penpulimab-kcqx every 3 weeks. Monotherapy is recommended at 200 mg ...

Despite the COVID-19 pandemic and related health care disruptions that caused a decrease in cancer incidence, overall cancer ...

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the ...

Panelists discuss how eliminating the strict mealtime restrictions with the new nilotinib formulation addresses a significant ...

The findings, which were presented at the 50th Annual Oncology Nursing Society Congress, showed that at a median follow-up of ...

The MindCap mobile app is likely feasible as an assessment for cognitive function of cancer survivors, although further data ...